C4X's discovery software shows early promise
Drug developer C4X Discovery's (C4XD:AIM) decision to buy a genetic analysis technology is showing promise. C4X bought Taxonomy3 for £1.7 million in March to strengthen its own drug discovery capabilities. The deal was entirely...
04 July 2016
